ChloroKlean Plus L20
A guide to regenerative chlorine dioxide, product-specific evidence, monitoring and the conditions that govern each intended use.
ChloroKlean Plus L20 is a liquid chlorine dioxide product described by its supplier as regenerative. Any release profile, residual persistence, efficacy and intended-use conditions must be confirmed from current product-specific evidence and verified in the system. Its stated Great Britain PT2, PT4, PT5 and PT11 uses are separate and cannot be treated as evidence of universal versatility or performance.
What Makes ChloroKlean Plus L20 Different
The term 'regenerative' describes a claimed release behaviour. It does not by itself establish continuous antimicrobial activity, a stable residual or protection against recontamination. Measure residual persistence under the actual conditions.
Packaged liquids, two-part products and generators have different preparation, storage, dosing, maintenance and monitoring requirements. Compare their documented risk controls and measured performance rather than assuming predictable residuals, lower operator risk or lower complexity.
Efficacy claims for Plus L20 must come from current product-specific evidence and match the named organism, concentration, contact time, matrix and use conditions. Results for chlorine dioxide generally, or for another formulation, are not Plus L20 dosing evidence. Suitability and safe use must be assessed separately for each intended application.
Multi-Sector BPR Compliance: PT2, PT4, PT5, and PT11
Plus L20 is supplied in Great Britain for stated PT2, PT4, PT5 and PT11 uses under applicable transitional arrangements while the relevant chlorine dioxide precursor-route and product-type combinations remain in the GB Review Programme. This is not a claim of full GB product authorisation, and no EU or Northern Ireland authorisation is claimed.
PT2 concerns supported private- and public-health disinfection uses, including relevant pool and spa applications. PT4 concerns food- and feed-area surfaces and equipment. PT5 concerns drinking water for people or animals. PT11 concerns preservation of cooling and processing liquids. The intended use, precursor route, product type and label must be checked for each application.
PT11 includes open and closed liquid-cooling and processing systems, but that category does not establish Plus L20 suitability for every circuit. Assess Plus L20 only where current label and technical documents support the intended use, considering system design, existing corrosion inhibitors, glycol, materials, operating conditions, dosing and monitoring.
No routine recommendation is made for inhibited closed heating or chilled-water loops without expressly supported current product instructions and written compatibility evidence. In a closed-circuit evaporative cooler, assess the external spray-water circuit separately from the enclosed process-fluid loop; support for spray-water treatment does not establish suitability for the enclosed loop.
For this transitional route, buyers should verify the applicable precursor-route and PT combination, Review Programme status and deadlines, the relevant Article 95 supply chain and other national requirements. Article 95 listing is not product authorisation or an efficacy finding.
Assessing Plus L20 Biofilm Claims
Published chlorine dioxide studies show biofilm effects under defined organism, matrix, surface, concentration and contact-time conditions. They do not establish particular Plus L20 effectiveness, prevention of re-establishment or progressive pipework cleaning without product-specific evidence and site verification.
The claimed regenerative behaviour and residual persistence of Plus L20 must be demonstrated by measurements in the actual system. General chlorine dioxide biofilm mechanisms do not prove that this product reaches or kills every embedded organism.
Any improvement in microbiological results, biofilm indicators, demand, residual stability, pipework condition or filter runs must be established against a recorded baseline. These outcomes should not be promised from the formulation alone.
For established biofilm problems, investigate cleaning, hydraulics, temperature and monitoring. Any remedial concentration and contact time must be supported by current Plus L20 product documentation and the site plan, not inferred from general chlorine dioxide studies.
Applications Across Key Sectors
Healthcare water systems require risk assessment, cleaning, temperature and hydraulic controls, monitoring and product-specific evidence. Plus L20 must not be presented as maintaining hygiene or avoiding corrosion and by-products without verification under the actual conditions.
Hospitality and leisure applications require separate assessment of each intended use. Chlorine dioxide forms no chloramines, but that does not establish air-quality, chemical-smell, irritation or guest-comfort outcomes. Ventilation and measured water and air quality remain necessary.
Food and beverage sites may use Plus L20 for stated surface, equipment or water uses where the label and applicable GB transitional route support them. PT4 and PT5 are separate classifications and evidence for one does not establish the other.
Industrial and commercial applications require separate review of product conditions, water chemistry, target organisms and material compatibility. Low-concentration efficacy and compatibility with copper, stainless steel, CPVC or PEX must be supported for the specific system.
Dosing, Monitoring, and Technical Support
Manual or automatic dosing suitability depends on the product conditions, application and site assessment. Automatic control does not itself guarantee consistent chlorine dioxide levels or reduced workload; representative measurement, alarms, calibration and operator response still require verification.
There is no generic Plus L20 residual or remedial dose that applies across water systems, pools, spas and surfaces. The current label and technical documentation must support the intended use, while a competent site plan accounts for volume, flow, temperature, demand, target organisms and verification.
Use a measurement method validated for the expected range and matrix, accounting for interferences and calibration. Monitor chlorine dioxide, chlorite and chlorate where required by the intended use and applicable drinking-water regime.
Product documentation includes the current Safety Data Sheet (SDS), Technical Data Sheet (TDS), application guidance and information supporting the applicable Great Britain transitional route. A product authorisation number is not claimed for Plus L20.
Product Specifications and Supply
ChloroKlean Plus L20 is supplied as a liquid concentrate in a range of pack sizes suitable for applications from small building water systems to large industrial installations. The product has a defined shelf life when stored in accordance with SDS recommendations - in a cool, dry, well-ventilated area away from direct sunlight and incompatible materials.
The product is manufactured to consistent quality standards with batch-level traceability. Every batch is tested for active concentration, purity, and stability before release. Certificates of analysis are available on request for applications requiring documented batch verification - including pharmaceutical, healthcare, and food manufacturing environments.
ChloroKlean supplies Plus L20 directly to end users and through approved water treatment contractors across the UK. We offer scheduled delivery, emergency supply for reactive situations, and technical support as part of our standard service. Volume pricing is available for larger installations and long-term supply agreements.
For organisations evaluating chlorine dioxide for the first time, ChloroKlean offers trial quantities of Plus L20 with full technical support to demonstrate performance in your specific application before committing to a full-scale transition. Contact our technical team to discuss trial arrangements.
GB BPR status and verification
ChloroKlean products are supplied for their stated Great Britain uses under applicable GB BPR transitional arrangements while the relevant chlorine dioxide precursor-route and product-type combinations remain in the GB Review Programme. This is not a claim of full product authorisation. No EU or Northern Ireland authorisation is claimed.
Verify the exact precursor route and product type, current Review Programme status and deadlines, the applicable GB Article 95 supply chain, product label and other national requirements. Article 95 listing is a supply-chain requirement, not product authorisation, an efficacy assessment or an HSE endorsement.
Key Data & Statistics
4 PTs
Stated GB transitional uses across PT2, PT4, PT5 and PT11
Site-specific
Residual and efficacy must follow current product conditions and verification
Site-specific
pH chemistry does not establish product efficacy
7
Available pack sizes from 500ml to 1000L IBC
ChloroKlean Plus L20 vs Alternative Disinfectants
How ChloroKlean Plus L20's regenerative chlorine dioxide compares to conventional disinfection chemicals.
| Feature | ChloroKlean Plus L20 (ClO₂) | Sodium Hypochlorite | Bromine (BCDMH) | Peracetic Acid |
|---|---|---|---|---|
| Active Substance | Regenerative chlorine dioxide | Free available chlorine | Hypobromous acid | Peracetic acid + H₂O₂ |
| GB BPR route | Transitional supply for stated PT2, PT4, PT5, PT11 uses | Varies by product | Varies by product | Varies by product |
| Biofilm evidence | Product and condition-specific | Product and condition-specific | Product and condition-specific | Product and condition-specific |
| Residual persistence | Measure under site conditions | Measure under site conditions | Measure under site conditions | Measure under site conditions |
| Disinfection By-Products | No chloramines; generally very little THM/HAA; measure chlorite/chlorate | THMs, chloramines and HAAs can form | Brominated THMs and bromate can form | Product- and process-specific |
| pH response | No hypochlorite-style dissociation; efficacy remains condition-specific | Active-species balance changes with pH | Active-species balance changes with pH | Follow product conditions |
| Legionella Efficacy | Product-specific conditions and site verification required | Product-specific conditions and site verification required | Product-specific conditions and site verification required | Product-specific conditions and site verification required |
| Intended uses | Check each stated use separately | Check each product separately | Check each product separately | Check each product separately |
Regenerative is a supplier description. Residual persistence and efficacy require current product evidence and site verification.
How to Get Started with ChloroKlean Plus L20
A step-by-step guide to evaluating and implementing ChloroKlean Plus L20 in your water treatment or disinfection programme.
Identify Your Disinfection Requirements
Document each intended use and identify the relevant product type. Record whether each candidate is authorised or transitionally supplied and note current products, dosing methods and performance issues.
Request a Free Technical Assessment
Contact ChloroKlean on +44 333 772 7379 or email hello@chloroklean.com with details of your installation. Our technical team will assess your system, review your current treatment programme, and recommend the appropriate Plus L20 dosing strategy and equipment specification for your specific application.
Review Product Documentation
Request the Plus L20 documentation package, including the precursor-route and product-type transitional evidence, Article 95 supply-chain information, current deadlines, Safety Data Sheet, Technical Data Sheet and application guidance. Review it against current HSE information, your COSHH assessment and written scheme.
Conduct a Trial
Where a controlled trial is appropriate and permitted, define acceptance criteria in advance and monitor residuals, by-products, microbiological results, biofilm indicators and operating conditions. Compare results with the baseline without presuming an improvement.
Implement Full-Scale Treatment
Use the trial evidence to decide whether each proposed use is supported. Before any wider transition, update the written scheme, COSHH assessment, monitoring procedures and product inventory, and retain competent review and verification.
Expert Insights
About the Reviewer
Gavin Owen
Managing Director, ChloroKlean
Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.
Related Products
BPR-compliant chlorine dioxide products available from ChloroKlean.
ChloroKlean Plus L20
Regenerative liquid chlorine dioxide supplied for stated PT2, PT4, PT5 and PT11 uses under applicable GB BPR transitional arrangements.
ChloroKlean Spa 500
Chlorine dioxide solution supplied for stated pool and spa uses under applicable GB BPR PT2 transitional arrangements.
ChloroKlean Surface Disinfectant
Surface disinfectant supplied for stated PT4 uses under applicable GB BPR transitional arrangements.
Frequently Asked Questions
Common questions about this topic, answered by our technical team.
Important Safety Information
- ChloroKlean Plus L20 must be stored, handled, and used in accordance with the current Safety Data Sheet and product label directions.
- Appropriate personal protective equipment (PPE) must be worn when handling concentrated Plus L20, including chemical-resistant gloves, safety goggles, and suitable protective clothing as specified in the SDS.
- Do not mix ChloroKlean Plus L20 with chlorine, bromine, acids, or any other chemicals unless specified in the product documentation. Mixing incompatible chemicals can release hazardous gases.
- A COSHH assessment must be completed before using Plus L20 in any application. The assessment should consider exposure routes, concentration, frequency of use, and risk mitigation measures.
- In drinking water applications (PT5), monitor chlorite and chlorate by-product levels to ensure compliance with DWI regulatory limits.
- Keep out of reach of children. Store in original containers in a cool, dry, well-ventilated area away from direct sunlight and incompatible materials.
This information is provided for guidance only and does not replace the product Safety Data Sheet or COSHH assessment. Always refer to the current SDS and seek professional advice where required. ChloroKlean Plus L20 is a biocidal product - use biocides safely and always read the label and product information before use. ChloroKlean products rely on applicable GB BPR transitional arrangements for stated Great Britain uses; Article 95 is not product authorisation, and no EU or Northern Ireland authorisation is claimed.
Related Resources
Continue exploring our knowledge base and product information.
BPR Compliant Disinfectant Guide
Understand GB BPR authorisation and lawful transitional supply, including the evidence needed for Plus L20's stated product types.
PT2 Disinfectant Explained
Understand PT2 uses and how to verify product authorisation or lawful transitional supply for the intended application.
Chlorine Dioxide vs Chlorine
Compare chlorine dioxide and chlorine evidence, by-products and operating conditions without assuming blanket superiority.
Chlorine Dioxide vs Bromine
How Plus L20's chlorine dioxide compares with bromine across efficacy, safety, and cost for pools, spas, and cooling towers.
Spa Water Disinfection Guide
How to assess Plus L20 and ChloroKlean Spa 500 within an HSG282 spa-water programme.
Chlorine Dioxide for Hot Tubs
How to assess Plus L20 and automatic dosing for commercial hot-tub treatment.
Chlorine Dioxide for Swimming Pools
How the absence of chloramine formation fits into a measured, site-specific pool-water programme.
Chlorine Dioxide UK Supplier
Why ChloroKlean is a trusted UK supplier - product range, regulatory compliance, and technical support.
Legionella Control Solutions
How Plus L20 supports Legionella risk management programmes under ACOP L8 and HSG274.
View Our Full Product Range
Explore ChloroKlean products and verify the applicable GB BPR transitional route for each stated use.
Contact Us
Request a free technical assessment, trial supply, or product documentation from our team.
Sources & References
This article references guidance from the following authoritative sources:
- Biocidal Products Regulation (BPR, Regulation (EU) 528/2012)
ECHA - European Chemicals Agency
- GB Biocidal Products Register
HSE - Health and Safety Executive
- GB Review Programme for existing biocidal active substances
HSE - Health and Safety Executive
- GB Article 95: the basics
HSE - Health and Safety Executive
- ACOP L8: Legionnaires' disease - Control of legionella bacteria in water systems
HSE - Health and Safety Executive
- HSG274 Part 2: The control of legionella bacteria in hot and cold water systems
HSE - Health and Safety Executive
- HSG282: The control of legionella and other infectious agents in spa-pool systems
HSE - Health and Safety Executive
- Guidelines for Drinking-water Quality - Chlorine Dioxide and Chlorite
WHO - World Health Organization
External links open in a new window. ChloroKlean is not responsible for the content of external websites.